Platelet-derived growth factor (PDGF) signaling is frequently aberrantly activated in GBM, primarily due to the amplification of the PDGF-receptor alpha (PDGFRA)25,26 (Supplementary Fig. 2a). The gene discussed is PDGFRA; the disease is glioblastoma.